Bramanti, S.; Taurino, D.; Magri, F.; De Philippis, C.; Sarina, B.; Castagna, L.; Giordano, L.; Mariotti, J.; Mannina, D.; Santoro, A.
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study. Life 2025, 15, 393.
https://doi.org/10.3390/life15030393
AMA Style
Bramanti S, Taurino D, Magri F, De Philippis C, Sarina B, Castagna L, Giordano L, Mariotti J, Mannina D, Santoro A.
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study. Life. 2025; 15(3):393.
https://doi.org/10.3390/life15030393
Chicago/Turabian Style
Bramanti, Stefania, Daniela Taurino, Filippo Magri, Chiara De Philippis, Barbara Sarina, Luca Castagna, Laura Giordano, Jacopo Mariotti, Daniele Mannina, and Armando Santoro.
2025. "Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study" Life 15, no. 3: 393.
https://doi.org/10.3390/life15030393
APA Style
Bramanti, S., Taurino, D., Magri, F., De Philippis, C., Sarina, B., Castagna, L., Giordano, L., Mariotti, J., Mannina, D., & Santoro, A.
(2025). Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study. Life, 15(3), 393.
https://doi.org/10.3390/life15030393
